1. Home
  2. DXCM vs XYL Comparison

DXCM vs XYL Comparison

Compare DXCM & XYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • XYL
  • Stock Information
  • Founded
  • DXCM 1999
  • XYL 2011
  • Country
  • DXCM United States
  • XYL United States
  • Employees
  • DXCM N/A
  • XYL N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • XYL Fluid Controls
  • Sector
  • DXCM Health Care
  • XYL Industrials
  • Exchange
  • DXCM Nasdaq
  • XYL Nasdaq
  • Market Cap
  • DXCM 31.7B
  • XYL 36.7B
  • IPO Year
  • DXCM 2005
  • XYL N/A
  • Fundamental
  • Price
  • DXCM $60.02
  • XYL $139.99
  • Analyst Decision
  • DXCM Strong Buy
  • XYL Buy
  • Analyst Count
  • DXCM 20
  • XYL 10
  • Target Price
  • DXCM $88.20
  • XYL $160.78
  • AVG Volume (30 Days)
  • DXCM 8.2M
  • XYL 1.2M
  • Earning Date
  • DXCM 10-30-2025
  • XYL 10-28-2025
  • Dividend Yield
  • DXCM N/A
  • XYL 1.14%
  • EPS Growth
  • DXCM 7.75
  • XYL 13.52
  • EPS
  • DXCM 1.80
  • XYL 3.88
  • Revenue
  • DXCM $4,515,900,000.00
  • XYL $8,894,000,000.00
  • Revenue This Year
  • DXCM $17.43
  • XYL $6.40
  • Revenue Next Year
  • DXCM $13.22
  • XYL $4.11
  • P/E Ratio
  • DXCM $32.55
  • XYL $36.34
  • Revenue Growth
  • DXCM 14.21
  • XYL 5.58
  • 52 Week Low
  • DXCM $54.11
  • XYL $100.48
  • 52 Week High
  • DXCM $93.25
  • XYL $154.27
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 43.00
  • XYL 29.75
  • Support Level
  • DXCM $57.20
  • XYL $149.20
  • Resistance Level
  • DXCM $60.85
  • XYL $151.99
  • Average True Range (ATR)
  • DXCM 2.52
  • XYL 2.73
  • MACD
  • DXCM 0.11
  • XYL -1.37
  • Stochastic Oscillator
  • DXCM 39.31
  • XYL 13.05

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About XYL Xylem Inc. New

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.

Share on Social Networks: